Industry Focus

Healthcare: Mylan's Big Biosimilar Bet

Listen Later
Mylan launches a biosimilar "at-risk" and Flexion's big drug opportunity becomes clearer.
...more
View all episodesView all episodes
Download on the App Store
Industry FocusBy The Motley Fool
  • 4.5
  • 4.5
  • 4.5
  • 4.5
  • 4.5

4.5

825 ratings

More shows like Industry Focus

View all
Motley Fool Money by The Motley Fool

Motley Fool Money

3,228 Listeners

Motley Fool Answers by The Motley Fool

Motley Fool Answers

807 Listeners

Rule Breaker Investing by The Motley Fool

Rule Breaker Investing

938 Listeners

MarketFoolery by The Motley Fool

MarketFoolery

1,604 Listeners